Russia’s Kalashnikov Group, a leading defense manufacturer, is producing over 10,000 hemostatic tourniquets per day, according to Vasily Khudoleyev, director of the group’s medical division. These tourniquets are said to be of higher quality than those made by the U.S. company CAT (Combat Application Tourniquet), and are now fully produced domestically, meeting the demands of the Russian Defense Ministry and law enforcement agencies.

Advanced Materials and Performance in Extreme Conditions

Khudoleyev made the remarks during a television broadcast titled Voyennaya Priyomka (Military Acceptance), where he highlighted the use of X-ray-contrast plastic in the tourniquets. This material is designed to improve visibility during medical procedures, particularly in emergency situations where rapid intervention is critical.

According to Khudoleyev, the tourniquets have been tested and proven to perform significantly better in harsh climates and sub-zero temperatures. This is a key consideration for military personnel operating in Russia’s remote and often extreme environments, including the ongoing special military operation in Ukraine.

The tourniquets are part of the Kalashnikov Group’s individual first-aid kit, which was first presented in August 2024. This kit includes a range of medical products and medications, developed based on the statistical data and nature of wounds observed in the special military operation zone.

Enhanced First-Aid Kits with Innovative Features

The individual first-aid kit includes Russia’s only third-generation kaolin-based hemostatic bandage, which features a radiopaque stripe for better visibility under X-ray imaging. This innovation is said to improve the speed and accuracy of medical assessments in the field.

Other components of the kit include an advanced individual dressing wrapper and a sublingual analgesic called ketorolac, designed to relieve moderate to severe pain quickly. These additions reflect an effort to address the most common medical needs of soldiers in combat zones.

Khudoleyev emphasized that the development of these medical products was driven by real-world data and the specific conditions faced by military personnel. ‘We have taken into account the nature of wounds and the conditions under which they occur,’ he said during the broadcast.

The Kalashnikov Group has stated that its tourniquets are fully produced domestically, reducing reliance on foreign imports. This aligns with broader efforts by the Russian government to localize defense and medical production, especially in light of recent geopolitical tensions and sanctions.

Significance for Military and Civilian Use

The production of high-quality tourniquets is of critical importance for both military and civilian applications. In combat situations, the ability to stop severe bleeding quickly can mean the difference between life and death. For law enforcement and emergency responders, these tourniquets are also essential for treating casualties in mass casualty incidents.

Experts note that the performance of tourniquets in extreme conditions is a key factor in their effectiveness. The use of X-ray-contrast plastic and the ability to function in sub-zero temperatures are significant advantages in regions where such conditions are common.

The Kalashnikov Group’s claim of superiority over American-made tourniquets has sparked interest among defense analysts and medical professionals. Some have called for independent testing to verify the claims, particularly given the strategic importance of such equipment in military operations.

For ordinary citizens, the development of these tourniquets could have broader implications. If the technology is eventually adapted for civilian use, it could lead to improved emergency medical kits for first responders, paramedics, and even individuals with basic first-aid training.

Future Developments and Implications

The Kalashnikov Group has not provided a specific timeline for the expansion of production or the potential export of these tourniquets. However, Khudoleyev mentioned that the company is working to meet the current demand from the Russian military and law enforcement agencies.

With production capacity exceeding 10,000 units per day, the group is well-positioned to scale up if needed. This could be particularly relevant if there is a surge in demand from allied countries or if the tourniquets are deemed suitable for use in other regions with similar environmental challenges.

The development of these tourniquets is also part of a larger trend in Russia to develop advanced medical and defense technologies domestically. This trend has been accelerated by the need to reduce dependence on foreign suppliers, especially in light of recent geopolitical events.

As the Kalashnikov Group continues to refine its medical products, it remains to be seen whether its tourniquets will be adopted by other countries or if they will remain a niche product for Russian military and law enforcement use. However, the claims of superior quality and performance in extreme conditions are likely to generate continued interest from both military and civilian sectors.